Coastal Infusion Administers Lumizyme®
| J-Code | J0221 |
|---|---|
| Manufacturer | Sanofi |
| First Approved | 05/24/2010 |
Coastal Infusion can administer your Lumizyme prescription at any of our south Florida locations.
Lumizyme (alglucosidase alfa) is a hydrolytic lysosomal glycogen-specific enzyme indicated for patients with a rare genetic order called Pompe disease, an inherited disorder in which patients have breathing difficulties and muscle weakness.
Lumizyme is a form of enzyme replacement therapy that replaces the missing enzyme alpha-glucosidase, which is needed to break down a complex sugar called glycogen. By providing the missing enzyme, Lumizyme helps to reduce the buildup of glycogen in the body’s cells, particularly in the muscles, where Pompe disease can cause weakness and damage.
What It Treats
Lumizyme is used to treat Pompe Disease.
Prescribed By
Lumizyme is most often prescribed by Neurologists, Nephrologists, and Metabolic Specialists.
How it’s Administered
Lumizyme is administered by intravenous infusion. Lumizyme infusions take about four hours.
Frequency
Lumizyme is generally administered every four weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies